Paul Audhya

Hoofd Techniek/Wetenschap/O&O bij KALVISTA PHARMACEUTICALS, INC.

Vermogen: 554 774 $ op 30-04-2024

51 jaar

Health Technology

Consumer Services

Actieve functies van Paul Audhya

Bedrijven	Functie	Begin	Einde
KALVISTA PHARMACEUTICALS, INC.	Hoofd Techniek/Wetenschap/O&O	03-05-2021	-

Bedrijven	Functie	Begin	Einde
ARENA PHARMACEUTICALS	Corporate Officer/Principal	26-11-2018	01-03-2021
VERTEX PHARMACEUTICALS INCORPORATED	Hoofd Techniek/Wetenschap/O&O	01-02-2016	01-09-2018
HOSPIRA, INC.	Hoofd Techniek/Wetenschap/O&O	01-06-2013	01-02-2016
REATA PHARMACEUTICALS, INC.	Hoofd Techniek/Wetenschap/O&O	04-07-2011	-

New York University	Undergraduate Degree
Pepperdine University	Masters Business Admin

Internationaal

Verenigde Staten

Operationeel

Chief Tech/Sci/R&D Officer	4
Undergraduate Degree	1
Corporate Officer/Principal	1

Sectoraal

Health Technology	6
Consumer Services	3

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
KALVISTA PHARMACEUTICALS, INC.	Health Technology
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology

Bedrijven in privébezit	3
Reata Pharmaceuticals, Inc. Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX.	Health Technology
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT.	Health Technology
Hospira, Inc. Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL.	Health Technology